Jushi Holdings (JUSHF) Non Operating Income (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Non Operating Income of -$9.9 million for Q2 2026, up 3.26% year-over-year from -$9.6 million in Q2 2025, and up 22.24% quarter-over-quarter from -$12.7 million in Q1 2026.
Jushi Holdings (JUSHF) Non Operating Income (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Non Operating Income for 6 consecutive years, with -$9.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non Operating Income rose 3.26% year-over-year to -$9.9 million; the TTM figure through Jun 2026 stood at -$50.2 million (down 28.51% YoY), while the FY2025 annual figure was -$40.8 million, down 9.14% from the prior year.
- Non Operating Income rose to -$9.9 million in Q2 2026 per JUSHF's latest filing, from -$12.7 million in the prior quarter.
- Across five years, Non Operating Income topped out at $31.9 million in Q2 2022 and bottomed at -$17.2 million in Q3 2025.
- Historically, Non Operating Income has averaged -$8.7 million across 5 years, with a median of -$10.1 million in 2022.
- Annual changes were most pronounced in 2022 — Non Operating Income surged 131.78% — and 2023, when it slumped 130.73%.
- Jushi Holdings' Non Operating Income stood at -$11.4 million in 2022, then climbed by 18.45% to -$9.3 million in 2023, then slipped by 1.26% to -$9.4 million in 2024, then fell by 9.87% to -$10.4 million in 2025, then climbed by 4.57% to -$9.9 million in 2026.
- Business Quant data shows JUSHF's Non Operating Income at -$9.9 million in Q2 2026, -$12.7 million in Q1 2026, and -$10.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -9.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.89 Mn |
| Mar 31, 2026 | -12.71 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Sep 30, 2025 | -17.20 Mn |
| Jun 30, 2025 | -10.22 Mn |
| Mar 31, 2025 | -10.00 Mn |
| Dec 31, 2024 | -9.43 Mn |
| Sep 30, 2024 | -9.38 Mn |
| Jun 30, 2024 | -9.07 Mn |
| Mar 31, 2024 | -12.73 Mn |
| Dec 31, 2023 | -9.31 Mn |
| Sep 30, 2023 | -15.44 Mn |
| Jun 30, 2023 | -9.79 Mn |
| Mar 31, 2023 | -8.52 Mn |
| Dec 31, 2022 | -11.42 Mn |
| Sep 30, 2022 | -13.11 Mn |
| Jun 30, 2022 | 31.85 Mn |
| Mar 31, 2022 | -10.12 Mn |
| Dec 31, 2021 | 40.86 Mn |
| Sep 30, 2021 | 47.84 Mn |